NT Mobile Menu

Search form


Alzheimer disease

Alzheimer disease

Dr. Lazzara reports on a study examining the effects of exercise on the cognitive function of older adults with mild cognitive impairment.

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Dr. Bobby Lazzara reports on a clinical trial of aducanumab, a human monoclonal antibody, in patients with prodromal or mild Alzheimer disease.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

Why is a lower BMI linked to greater dementia risks in the elderly? Dr. Bobby Lazzara discusses a recent analysis using the Harvard Aging Brain Study.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Recent neurological studies outline a link between TBI and Parkinson disease, discuss neuroimaging to predict recovery, and warn against DIY tDCS.


Subscribe to Alzheimer disease on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.